Yi Guan

Dr. Yi Guan


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2024 in Redox Biology
Verified
Journal Article
Open access
SZSanqiao Qiang Zhou
Sanqiao Qiang Zhou
YGYi Guan
Yi Guan
CMChang Meiyu
Chang Meiyu
LNLi Ning
Li Ning
YBYichun Bai
Yichun Bai
SYSanqiao Yao
Sanqiao Yao
Silicosis, characterized by interstitial lung inflammation and fibrosis, poses a significant health threat. ATII cells play a crucial role in alveolar epithelial repair and structural integrity maintenance. Inhibiting ATII cell senescence has shown promise in silicosis treatment. However, the mechanism behind silica-induced senescence remains elusive. The study employed male C57BL/6 N mice and A549 human alveolar epithelial cells to investigate silicosis and its potential treatment. Silicosis was induced in mice via intratracheal instillation of crystalline silica particles, with honokiol administered intraperitoneally for 14 days. Silica-induced senescence in A549 cells was confirmed, and SIRT3 knockout and overexpression cell lines were generated. Various analyses were conducted, including immunoblotting, qRT-PCR, histology, and transmission electron microscopy. Statistical significance was determined using one-way ANOVA with Tukey's post-hoc test. This study elucidates how silica induces ATII cell senescence, emphasizing mtDNA damage. Notably, honokiol (HKL) emerges as a promising anti-senescence and anti-fibrosis agent, acting through sirt3. honokiol effectively attenuated senescence in ATII cells, dependent on sirt3 expression, while mitigating mtDNA damage. Sirt3, a class III histone deacetylase, regulates senescence and mitochondrial stress. HKL activates sirt3, protecting against pulmonary fibrosis and mitochondrial damage. Additionally, HKL downregulated cGAS expression in senescent ATII cells induced by silica, suggesting sirt3's role as an upstream regulator of the cGAS/STING signaling pathway. Moreover, honokiol treatment inhibited the activation of the NF-κB signaling pathway, associated with reduced oxidative stress and mtDNA damage. Notably, HKL enhanced the activity of SOD2, crucial for mitochondrial function, through sirt3-mediated deacetylation. Additionally, HKL promoted the deacetylation activity of sirt3, further safeguarding mtDNA integrity. This study uncovers a natural compound, HKL, with significant anti-fibrotic properties through activating sirt3, shedding light on silicosis pathogenesis and treatment avenues.

22 September 2022 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
LNLi Ning
Li Ning
LZLin Zhang
Lin Zhang
SZSanqiao Qiang Zhou
Sanqiao Qiang Zhou
MCMeiyu Chang
Meiyu Chang
YWYongheng Wang
Yongheng Wang
SYSanqiao Yao
Sanqiao Yao
Silicosis is a severe progressive lung disease without effective treatment methods. Previous evidence has demonstrated that endothelial cell to mesenchymal transition (EndoMT) plays an essential role in pulmonary fibrosis, and pulmonary fibrosis is associated with dysregulation of autophagy, while the relationship between autophagy and EndoMT has not yet been adequately studied. Herein, we established a mouse model of silicosis, and we found that the pharmacological induction of the AMPK/mTOR-dependent pathway using 100 mg/kg Metformin (Met) enhanced autophagy in vivo, and results of the Western blot showed that autophagy-related proteins, LC3 II/I ratio, and Beclin-1 increased while p62 decreased. In addition, Met treatment attenuated silica-induced pulmonary inflammation and decreased collagen deposition by suppressing EndoMT, and the proliferation of human umbilical vein endothelial cells (HUVECs) was also inhibited. Notably, the tube forming assay showed that Met also protected the vascular endothelial cells from silica-induced morphological damage. In conclusion, Met can alleviate inflammatory response and collagen deposition in the process of pulmonary fibrosis induced by silica via suppressing EndoMT through the AMPK/mTOR signaling pathway.

16 January 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
ALAng Li
Ang Li
PCPing Cui
Ping Cui
LLLili Liu
Lili Liu
JLJiawei Liu
Jiawei Liu
XZXianlei Zhou
Xianlei Zhou
HZHongmei Zhang
Hongmei Zhang
Background: This study aims to define a novel molecular subtype of LUAD by integrating multiple omics data. Additionally, we develop and validate an Artificial Intelligence Derived Prognostic Index (AIDPI) that predicts the prognosis of LUAD patients, identifies potential therapeutic targets. Methods: This study employed ten clustering algorithms from the R package “MOVICS” to integrate multi-omics data of LUAD sourced from TCGA database for molecular typing. Subsequently, an Artificial Intelligence Derived Prognostic Index (AIDPI) was constructed as the most effective indicator for predicting the overall survival rate of LUAD patients. The biological functions and mechanisms of NPC2 in lung adenocarcinoma were elucidated through both in vitro and in vivo experiments, which included CCK-8 assays, colony formation assays, flow cytometry, Transwell assays, and xenograft tumor models. Additionally, the impact of NPC2 on Ribociclib sensitivity was investigated through drug correlation analysis and molecular docking, while the predictive value of NPC2 regarding immunotherapy benefits was validated using the immune cell infiltration analysis. Results: Through multi-omics clustering, we identified two subtypes of lung adenocarcinoma associated with prognosis, with the CS1 subtype exhibiting the most favorable prognostic outcomes. The low AIDPI group exhibited a more positive prognosis, accompanied by increased immune cell infiltration and activation of immune pathways. Meanwhile, NPC2 was recognized as a standalone risk factor for LUAD, with its high expression significantly improving the overall survival of LUAD patients. Functionally, the overexpression of NPC2 promotes tumorigenesis in LUAD both in vitro and in vivo . Mechanistically, the upregulation of NPC2 expression inhibits the progression of LUAD by suppressing the PI3K/AKT signaling pathway. Our study also demonstrated that high NPC2 expression is positively correlated with Ribociclib sensitivity, as confirmed by in vitro experiments. Furthermore, NPC2 expression is positively correlated with ImmuneScore, and may serve as a predictive indicator for the efficacy of immune checkpoint inhibitor (ICI) therapy. Conclusion: The comprehensive analysis of multiple omics data significantly enhances the molecular classification of lung adenocarcinoma. Furthermore, AIDPI is a potential biomarker that predicts the prognosis of LUAD patients. NPC2 inhibits the progression of LUAD by suppressing the PI3K/AKT signaling pathway and enhancing the chemotherapy sensitivity to Ribociclib.

14 April 2026 in Biological Trace Element Research
Verified
Journal Article
Closed access
YLYi Luo
Yi Luo
WSWei Su
Wei Su
YLYong Luo
Yong Luo
YHYanting Han
Yanting Han
SGShuwen Gong
Shuwen Gong
JLJinlong Li
Jinlong Li